Developing Pan-Variant TKIs to Fight Treatment Resistant Cancer Mutations with Tim Clackson Theseus Pharmaceuticals TRANSCRIPT
Download PDFFeb 28, 2022
Tim Clackson is the President and CEO of Theseus Pharmaceuticals which has a mission to outsmart cancer resistance by developing pan-variant tyrosine kinase inhibitors (TKIs) that are designed to hit different types of cancer cell mutations. The goals of the therapy are to delay treatment resistant cancer as well as...
Feb 28, 2022
Tim Clackson is the President and CEO of Theseus Pharmaceuticals which has a mission to outsmart cancer resistance by developing pan-variant tyrosine kinase inhibitors (TKIs) that are designed to hit different types of cancer cell mutations. The goals of the therapy are to delay treatment resistant cancer as well as...
Feb 24, 2022
Dr. John Krakauer is the Chief Medical Advisor at MindMaze, pioneers in digital neurotherapeutics focused on brain health and recovery from neurological diseases and injuries.
John explains, "What we really mean by digital neurotherapeutics is the belief that one can actually administer a medicine in a way that's...
Advocating for Patient Access to Family and Care Providers with Emee Baldwin Poppy’s Purpose TRANSCRIPT
Download PDFFeb 23, 2022
Emee Baldwin, Founder of Poppy's Purpose, is a nursing student and patient advocate with a success story about getting the attention of care providers and elected officials to re-evaluate the rules regarding patient visitation rights, particularly in the age of COVID-19. Emee and her family worked with their local...
Feb 23, 2022
Emee Baldwin, Founder of Poppy's Purpose, is a nursing student and patient advocate with a success story about getting the attention of care providers and elected officials to re-evaluate the rules regarding patient visitation rights, particularly in the age of COVID-19. Emee and her family worked with their local...